The Relationship Between Superior Vena Cava Flow and Intraventricular Hemorrhage in Preterm Infants
Study to Assess the Relationship Between Superior Vena Cava Flow and Intraventricular Hemorrhage in Preterm Infants
1 other identifier
observational
50
1 country
1
Brief Summary
The aim of the study was to evaluate the relationship between superior vena cava (SVC) flow measurements within the first 24 hours of life and development of intraventricular hemorrhage in preterm born infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2020
CompletedFirst Submitted
Initial submission to the registry
September 10, 2021
CompletedFirst Posted
Study publicly available on registry
September 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedJune 15, 2022
June 1, 2022
1.4 years
September 10, 2021
June 13, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Superior vena cava (SVC) flow
This was measured using echocardiography. SVC diameter will be visualized from a high parasternal long axis view. The maximum and minimum internal diameters will be then measured off-line from a frozen two-dimensional image showing the vessel walls at the point where SVC starts to open up into the right atrium. Mean of the maximum and minimum diameter used for the flow calculation. * SVC flow velocity will be visualized from a low subcostal view and the pulsed Doppler recording will be made at the junction of the SVC and the right atrium. Velocity time integral (VTI) will be calculated from the Doppler velocity tracings and averaged over 5 consecutive cardiac cycles. * SVC flow will be calculated using the method described by Kluckow and Evans: SVC flow (ml/kg/min) = {VTI (cm/beat) × 3.14 × (mean SVC diameter2/4) × heart rate (beat/min) }/body weight in kg
Day 1
Intraventricular hemorrhage (IVH) assessment
Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * Cranial ultrasound will be done and any IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension
Day 1
Intraventricular hemorrhage (IVH) assessment
Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension
Day 3
Intraventricular hemorrhage (IVH) assessment
Cranial ultrasound will be performed after the echocardiography: * Machine: model GE Vivid iq premium. * Probe: GE 8C-RS probe with a frequency range of 3.5 - 10 MHz. * Cranial ultrasound will be done and any IVH will be noted and classified according to Papile grading: Grade I: Hemorrhage limited to germinal matrix Grade II: Blood noted within the ventricular system but not distending it Grade III: Blood in the ventricles with distension of the ventricles Grade IV: Intraventricular hemorrhage with parenchymal extension
Day 7
Anterior cerebral artery (ACA) flow velocity assessment
Transcranial Doppler (TCD) ultrasonography was used to assess the anterior cerebral artery flow velocity
Day 1
Eligibility Criteria
Newborns with very low birth weight (≤1500 g) or ≤ 32 weeks gestation who were admitted to neonatal intensive care unit in the first day of life where evaluation of the relationship between superior vena cava (SVC) flow measurements within the first 24 hours of life and development of intraventricular hemorrhage were assessed.
You may qualify if:
- Newborns with very low birth weight (≤1500 g) or ≤ 32 weeks gestation who were admitted to neonatal intensive care unit in the first day of life.
You may not qualify if:
- Newborns (more than 32 weeks of gestation
- Newborns with birth weight more than 1500 g.
- Newborns with congenital heart diseases excluding (patent ductus arteriosus and patent foramen ovale)
- Newborns with major congenital malformations.
- Newborns with birth trauma especially basal skull/temporal bone fractures that require hospitalization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.
Alexandria, 21131, Egypt
Related Publications (3)
Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F182-7. doi: 10.1136/fn.82.3.f182.
PMID: 10794783BACKGROUNDPapile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529-34. doi: 10.1016/s0022-3476(78)80282-0.
PMID: 305471BACKGROUNDFarag MM, Gouda MH, Almohsen AMA, Khalifa MA. Intraventricular hemorrhage prediction in premature neonates in the era of hemodynamics monitoring: a prospective cohort study. Eur J Pediatr. 2022 Dec;181(12):4067-4077. doi: 10.1007/s00431-022-04630-5. Epub 2022 Sep 28.
PMID: 36171508DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed AM Khalifa, MBBCh
Faculty of Medicine, Alexandria University, Egypt
- STUDY DIRECTOR
Mohamed H Gouda, PhD
Faculty of Medicine, Alexandria University, Egypt
- STUDY DIRECTOR
Ali M Abd Almohsen, PhD
Faculty of Medicine, Alexandria University, Egypt
- STUDY CHAIR
Marwa M Farag, PhD
Faculty of Medicine, Alexandria University, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer in Pediatrics, Faculty of Medicine
Study Record Dates
First Submitted
September 10, 2021
First Posted
September 20, 2021
Study Start
May 10, 2020
Primary Completion
September 20, 2021
Study Completion
October 1, 2021
Last Updated
June 15, 2022
Record last verified: 2022-06